The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trials of hydroxychloroquine and lopinavir/ritonavir to treat COVID-19 patients.
The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trials of hydroxychloroquine and lopinavir/ritonavir to treat COVID-19 patients.
The United States track and field trials for the Tokyo Olympics will take place on June 18-27 next year following the postponement of the Games due to the coronavirus pandemic.